Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Tobacco Use 1Tobacco Smoking 1Oropharyngeal Neoplasms 1Neoplasms 1Health Behavior 1Colorectal Neoplasms 1

Interventions

Cisplatin 56Radiotherapy 34Radiotherapy, Intensity-Modulated 28Magnetic Resonance Spectroscopy 24Radiation 20Carboplatin 19pembrolizumab 17Specimen Handling 16Platinum 141,2-diaminocyclohexaneplatinum II citrate 14Paclitaxel 13Cetuximab 13Fluorouracil 10Surgical Procedures, Operative 9Docetaxel 9Biopsy 9Taxes 8Chemoradiotherapy 8Nivolumab 7Fluorodeoxyglucose F18 7Drug Therapy 7durvalumab 6Surveys and Questionnaires 6fludarabine 5X-Rays 5Observation 5Cyclophosphamide 5aldesleukin 4Standard of Care 4Radiosurgery 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Oropharyngeal Neoplasms × Costs and Cost Analysis × Clear all
NCT05307939 2026-04-13

A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
30 enrolled
Head & Neck

Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡